Hmdb loader

Showing metabocard for (R)-2,3-Dihydroxy-isovalerate (HMDB0012141)

Jump To Section:
IdentificationTaxonomyOntologyPhysical propertiesSpectraBiological propertiesConcentrationsLinksReferencesXML
Record Information
Version5.0
StatusDetected and Quantified
Creation Date2009-04-06 16:19:54 UTC
Update Date2023-02-21 17:17:40 UTC
HMDB IDHMDB0012141
Secondary Accession Numbers
  • HMDB12141
Metabolite Identification
Common Name(R)-2,3-Dihydroxy-isovalerate
Description(R) 2,3-Dihydroxy-isovalerate is an intermediate in valine, leucine and isoleucine biosynthesis. The pathway of valine biosynthesis is a four-step pathway that shares all of its steps with the parallel pathway of isoleucine biosynthesis. These entwined pathways are part of the superpathway of leucine, valine, and isoleucine biosynthesis , that generates not only isoleucine and valine, but also leucine. (R) 2,3-Dihydroxy-isovalerate is generated from 3-Hydroxy-3-methyl-2-oxobutanoic acid via the enzyme ketol-acid reductoisomerase (EC 1.1.1.86) then it is converted to 2-Oxoisovalerate via the dihydroxy-acid dehydratase (EC:4.2.1.9).
Structure
Data?1676999860
MOL3D MOLSDF3D SDFPDB3D PDBSMILESInChI

MOL for HMDB0012141 ((R)-2,3-Dihydroxy-isovalerate)


  Mrv1652309182022292D          

  9  8  0  0  0  0            999 V2000
10001.245110001.0646    0.0000 C   0  0  2  0  0  0  0  0  0  0  0  0
10001.960110001.4763    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
10000.529910001.4763    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
10001.245110000.2400    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
10002.674110001.0646    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
10002.371310002.1915    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
10001.546810002.1915    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
 9999.816810001.0646    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
10000.529910002.3008    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  1  0  0  0
  2  5  1  0  0  0  0
  2  6  1  0  0  0  0
  2  7  1  0  0  0  0
  3  8  1  0  0  0  0
  3  9  2  0  0  0  0
M  END
Download

3D MOL for HMDB0012141 ((R)-2,3-Dihydroxy-isovalerate)

HMDB0012141
     RDKit          3D
(R)-2,3-Dihydroxy-isovalerate
 19 18  0  0  0  0  0  0  0  0999 V2000
   -0.6384   -0.9481   -0.9933 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4435    0.3272   -0.2087 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7846    0.7099    0.3735 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0172    1.3757   -1.0010 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.5667    0.0586    0.8903 C   0  0  1  0  0  0  0  0  0  0  0  0
    0.1327   -0.9977    1.6846 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.8902   -0.2712    0.3177 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4123   -1.3670    0.5947 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.5754    0.5999   -0.5212 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.2829   -1.2293   -1.5228 H   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8663   -1.7581   -0.2739 H   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5243   -0.8480   -1.6449 H   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6750    1.3295    1.2857 H   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4219   -0.1557    0.6006 H   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3380    1.3391   -0.3613 H   0  0  0  0  0  0  0  0  0  0  0  0
    0.3312    2.0818   -0.4077 H   0  0  0  0  0  0  0  0  0  0  0  0
    0.6122    0.9753    1.5332 H   0  0  0  0  0  0  0  0  0  0  0  0
    0.4410   -1.8664    1.3502 H   0  0  0  0  0  0  0  0  0  0  0  0
    2.4644    0.6444   -1.5077 H   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  2  5  1  0
  5  6  1  0
  5  7  1  0
  7  8  2  0
  7  9  1  0
  1 10  1  0
  1 11  1  0
  1 12  1  0
  3 13  1  0
  3 14  1  0
  3 15  1  0
  4 16  1  0
  5 17  1  1
  6 18  1  0
  9 19  1  0
M  END
Download

3D SDF for HMDB0012141 ((R)-2,3-Dihydroxy-isovalerate)


  Mrv1652309182022292D          

  9  8  0  0  0  0            999 V2000
10001.245110001.0646    0.0000 C   0  0  2  0  0  0  0  0  0  0  0  0
10001.960110001.4763    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
10000.529910001.4763    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
10001.245110000.2400    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
10002.674110001.0646    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
10002.371310002.1915    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
10001.546810002.1915    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
 9999.816810001.0646    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
10000.529910002.3008    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  3  1  0  0  0  0
  1  4  1  1  0  0  0
  2  5  1  0  0  0  0
  2  6  1  0  0  0  0
  2  7  1  0  0  0  0
  3  8  1  0  0  0  0
  3  9  2  0  0  0  0
M  END
> <DATABASE_ID>
HMDB0012141

> <DATABASE_NAME>
hmdb

> <SMILES>
CC(C)(O)[C@@H](O)C(O)=O

> <INCHI_IDENTIFIER>
InChI=1S/C5H10O4/c1-5(2,9)3(6)4(7)8/h3,6,9H,1-2H3,(H,7,8)/t3-/m0/s1

> <INCHI_KEY>
JTEYKUFKXGDTEU-VKHMYHEASA-N

> <FORMULA>
C5H10O4

> <MOLECULAR_WEIGHT>
134.1305

> <EXACT_MASS>
134.057908808

> <JCHEM_ACCEPTOR_COUNT>
4

> <JCHEM_ATOM_COUNT>
19

> <JCHEM_AVERAGE_POLARIZABILITY>
12.481918919422833

> <JCHEM_BIOAVAILABILITY>
1

> <JCHEM_DONOR_COUNT>
3

> <JCHEM_FORMAL_CHARGE>
0

> <JCHEM_GHOSE_FILTER>
0

> <JCHEM_IUPAC>
(2R)-2,3-dihydroxy-3-methylbutanoic acid

> <ALOGPS_LOGP>
-0.83

> <JCHEM_LOGP>
-0.8215877916666663

> <ALOGPS_LOGS>
0.60

> <JCHEM_MDDR_LIKE_RULE>
0

> <JCHEM_NUMBER_OF_RINGS>
0

> <JCHEM_PHYSIOLOGICAL_CHARGE>
-1

> <JCHEM_PKA>
13.137895474801091

> <JCHEM_PKA_STRONGEST_ACIDIC>
3.7976532415810835

> <JCHEM_PKA_STRONGEST_BASIC>
-3.2052703412545993

> <JCHEM_POLAR_SURFACE_AREA>
77.75999999999999

> <JCHEM_REFRACTIVITY>
29.4405

> <JCHEM_ROTATABLE_BOND_COUNT>
2

> <JCHEM_RULE_OF_FIVE>
1

> <ALOGPS_SOLUBILITY>
5.29e+02 g/l

> <JCHEM_TRADITIONAL_IUPAC>
(R)-2,3-dihydroxy-isovalerate

> <JCHEM_VEBER_RULE>
0

$$$$
Download

3D-SDF for HMDB0012141 ((R)-2,3-Dihydroxy-isovalerate)

HMDB0012141
     RDKit          3D
(R)-2,3-Dihydroxy-isovalerate
 19 18  0  0  0  0  0  0  0  0999 V2000
   -0.6384   -0.9481   -0.9933 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4435    0.3272   -0.2087 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7846    0.7099    0.3735 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0172    1.3757   -1.0010 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.5667    0.0586    0.8903 C   0  0  1  0  0  0  0  0  0  0  0  0
    0.1327   -0.9977    1.6846 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.8902   -0.2712    0.3177 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4123   -1.3670    0.5947 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.5754    0.5999   -0.5212 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.2829   -1.2293   -1.5228 H   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8663   -1.7581   -0.2739 H   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5243   -0.8480   -1.6449 H   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6750    1.3295    1.2857 H   0  0  0  0  0  0  0  0  0  0  0  0
   -2.4219   -0.1557    0.6006 H   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3380    1.3391   -0.3613 H   0  0  0  0  0  0  0  0  0  0  0  0
    0.3312    2.0818   -0.4077 H   0  0  0  0  0  0  0  0  0  0  0  0
    0.6122    0.9753    1.5332 H   0  0  0  0  0  0  0  0  0  0  0  0
    0.4410   -1.8664    1.3502 H   0  0  0  0  0  0  0  0  0  0  0  0
    2.4644    0.6444   -1.5077 H   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  2  4  1  0
  2  5  1  0
  5  6  1  0
  5  7  1  0
  7  8  2  0
  7  9  1  0
  1 10  1  0
  1 11  1  0
  1 12  1  0
  3 13  1  0
  3 14  1  0
  3 15  1  0
  4 16  1  0
  5 17  1  1
  6 18  1  0
  9 19  1  0
M  END
Download

PDB for HMDB0012141 ((R)-2,3-Dihydroxy-isovalerate)

HEADER    PROTEIN                                 18-SEP-20   NONE
TITLE     NULL                                                        
COMPND    NULL                                                        
SOURCE    NULL                                                        
KEYWDS    NULL                                                        
EXPDTA    NULL                                                        
AUTHOR    Marvin                                                      
REVDAT   1   18-SEP-20         0                                  
HETATM    1  C   UNK     0    8668.9918668.654   0.000  0.00  0.00           C+0
HETATM    2  C   UNK     0    8670.3258669.422   0.000  0.00  0.00           C+0
HETATM    3  C   UNK     0    8667.6568669.422   0.000  0.00  0.00           C+0
HETATM    4  O   UNK     0    8668.9918667.115   0.000  0.00  0.00           O+0
HETATM    5  C   UNK     0    8671.6588668.654   0.000  0.00  0.00           C+0
HETATM    6  C   UNK     0    8671.0938670.757   0.000  0.00  0.00           C+0
HETATM    7  O   UNK     0    8669.5548670.757   0.000  0.00  0.00           O+0
HETATM    8  O   UNK     0    8666.3258668.654   0.000  0.00  0.00           O+0
HETATM    9  O   UNK     0    8667.6568670.962   0.000  0.00  0.00           O+0
CONECT    1    2    3    4                                                  
CONECT    2    1    5    6    7                                             
CONECT    3    1    8    9                                                  
CONECT    4    1                                                            
CONECT    5    2                                                            
CONECT    6    2                                                            
CONECT    7    2                                                            
CONECT    8    3                                                            
CONECT    9    3                                                            
MASTER        0    0    0    0    0    0    0    0    9    0   16    0
END
Download

3D PDB for HMDB0012141 ((R)-2,3-Dihydroxy-isovalerate)

COMPND    HMDB0012141
HETATM    1  C1  UNL     1      -0.638  -0.948  -0.993  1.00  0.00           C  
HETATM    2  C2  UNL     1      -0.443   0.327  -0.209  1.00  0.00           C  
HETATM    3  C3  UNL     1      -1.785   0.710   0.373  1.00  0.00           C  
HETATM    4  O1  UNL     1      -0.017   1.376  -1.001  1.00  0.00           O  
HETATM    5  C4  UNL     1       0.567   0.059   0.890  1.00  0.00           C  
HETATM    6  O2  UNL     1       0.133  -0.998   1.685  1.00  0.00           O  
HETATM    7  C5  UNL     1       1.890  -0.271   0.318  1.00  0.00           C  
HETATM    8  O3  UNL     1       2.412  -1.367   0.595  1.00  0.00           O  
HETATM    9  O4  UNL     1       2.575   0.600  -0.521  1.00  0.00           O  
HETATM   10  H1  UNL     1       0.283  -1.229  -1.523  1.00  0.00           H  
HETATM   11  H2  UNL     1      -0.866  -1.758  -0.274  1.00  0.00           H  
HETATM   12  H3  UNL     1      -1.524  -0.848  -1.645  1.00  0.00           H  
HETATM   13  H4  UNL     1      -1.675   1.330   1.286  1.00  0.00           H  
HETATM   14  H5  UNL     1      -2.422  -0.156   0.601  1.00  0.00           H  
HETATM   15  H6  UNL     1      -2.338   1.339  -0.361  1.00  0.00           H  
HETATM   16  H7  UNL     1       0.331   2.082  -0.408  1.00  0.00           H  
HETATM   17  H8  UNL     1       0.612   0.975   1.533  1.00  0.00           H  
HETATM   18  H9  UNL     1       0.441  -1.866   1.350  1.00  0.00           H  
HETATM   19  H10 UNL     1       2.464   0.644  -1.508  1.00  0.00           H  
CONECT    1    2   10   11   12
CONECT    2    3    4    5
CONECT    3   13   14   15
CONECT    4   16
CONECT    5    6    7   17
CONECT    6   18
CONECT    7    8    8    9
CONECT    9   19
END
Download

SMILES for HMDB0012141 ((R)-2,3-Dihydroxy-isovalerate)

CC(C)(O)[C@@H](O)C(O)=O
Download

INCHI for HMDB0012141 ((R)-2,3-Dihydroxy-isovalerate)

InChI=1S/C5H10O4/c1-5(2,9)3(6)4(7)8/h3,6,9H,1-2H3,(H,7,8)/t3-/m0/s1
Download
View in JSmolView NMR AssignmentsView Stereo Labels
Synonyms
ValueSource
(R)-2,3-Dihydroxy-isovaleric acidChEBI
(2R)-2,3-Dihydroxy-3-methylbutanoateKegg
(2R)-2,3-Dihydroxy-3-methylbutanoic acidGenerator
(R)-2,3-Dihydroxy-3-methylbutanoateHMDB
(R)-2,3-Dihydroxy-3-methylbutanoic acidHMDB
(R)-(-)-alpha,beta-Dihydroxyisovaleric acidHMDB
(R)-(-)-α,β-Dihydroxyisovaleric acidHMDB
(R)-2,3-Dihydroxy-isovalerateHMDB
Chemical FormulaC5H10O4
Average Molecular Weight134.1305
Monoisotopic Molecular Weight134.057908808
IUPAC Name(2R)-2,3-dihydroxy-3-methylbutanoic acid
Traditional Name(R)-2,3-dihydroxy-isovalerate
CAS Registry Number19451-56-0
SMILES
CC(C)(O)[C@@H](O)C(O)=O
InChI Identifier
InChI=1S/C5H10O4/c1-5(2,9)3(6)4(7)8/h3,6,9H,1-2H3,(H,7,8)/t3-/m0/s1
InChI KeyJTEYKUFKXGDTEU-VKHMYHEASA-N
Chemical Taxonomy
Description Belongs to the class of organic compounds known as hydroxy fatty acids. These are fatty acids in which the chain bears a hydroxyl group.
KingdomOrganic compounds
Super ClassLipids and lipid-like molecules
ClassFatty Acyls
Sub ClassFatty acids and conjugates
Direct ParentHydroxy fatty acids
Alternative Parents
Substituents
  • Branched fatty acid
  • Methyl-branched fatty acid
  • Short-chain hydroxy acid
  • Hydroxy fatty acid
  • Alpha-hydroxy acid
  • Hydroxy acid
  • Monosaccharide
  • Tertiary alcohol
  • 1,2-diol
  • Secondary alcohol
  • Carboxylic acid derivative
  • Carboxylic acid
  • Monocarboxylic acid or derivatives
  • Organic oxygen compound
  • Carbonyl group
  • Hydrocarbon derivative
  • Organic oxide
  • Alcohol
  • Organooxygen compound
  • Aliphatic acyclic compound
Molecular FrameworkAliphatic acyclic compounds
External Descriptors
Ontology
Not AvailableNot Available
Physical Properties
StateSolid
Experimental Molecular Properties
PropertyValueReference
Melting PointNot AvailableNot Available
Boiling PointNot AvailableNot Available
Water SolubilityNot AvailableNot Available
LogPNot AvailableNot Available
Experimental Chromatographic PropertiesNot Available
Predicted Molecular Properties
PropertyValueSource
Water Solubility529 g/LALOGPS
logP-0.83ALOGPS
logP-0.82ChemAxon
logS0.6ALOGPS
pKa (Strongest Acidic)3.8ChemAxon
pKa (Strongest Basic)-3.2ChemAxon
Physiological Charge-1ChemAxon
Hydrogen Acceptor Count4ChemAxon
Hydrogen Donor Count3ChemAxon
Polar Surface Area77.76 ŲChemAxon
Rotatable Bond Count2ChemAxon
Refractivity29.44 m³·mol⁻¹ChemAxon
Polarizability12.48 ųChemAxon
Number of Rings0ChemAxon
BioavailabilityYesChemAxon
Rule of FiveYesChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted Chromatographic Properties

Predicted Collision Cross Sections

PredictorAdduct TypeCCS Value (Å2)Reference
DarkChem[M+H]+128.8631661259
DarkChem[M-H]-124.23231661259
DeepCCS[M+H]+126.72630932474
DeepCCS[M-H]-122.89730932474
DeepCCS[M-2H]-160.16430932474
DeepCCS[M+Na]+135.630932474
AllCCS[M+H]+131.832859911
AllCCS[M+H-H2O]+127.832859911
AllCCS[M+NH4]+135.632859911
AllCCS[M+Na]+136.732859911
AllCCS[M-H]-125.832859911
AllCCS[M+Na-2H]-128.632859911
AllCCS[M+HCOO]-131.732859911

Predicted Retention Times

Underivatized

Chromatographic MethodRetention TimeReference
Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. 1.41 minutes32390414
Predicted by Siyang on May 30, 20229.7619 minutes33406817
Predicted by Siyang using ReTip algorithm on June 8, 20224.12 minutes32390414
AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid205.8 seconds40023050
Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid817.5 seconds40023050
Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid342.7 seconds40023050
Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid62.6 seconds40023050
Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid195.4 seconds40023050
RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid47.1 seconds40023050
Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid287.9 seconds40023050
BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid288.2 seconds40023050
HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate)181.2 seconds40023050
UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid623.8 seconds40023050
BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid83.1 seconds40023050
UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid777.8 seconds40023050
SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid199.4 seconds40023050
RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid256.4 seconds40023050
MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate518.6 seconds40023050
KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA297.7 seconds40023050
Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water263.3 seconds40023050

Predicted Kovats Retention Indices

Underivatized

MetaboliteSMILESKovats RI ValueColumn TypeReference
(R)-2,3-Dihydroxy-isovalerateCC(C)(O)[C@@H](O)C(O)=O2348.5Standard polar33892256
(R)-2,3-Dihydroxy-isovalerateCC(C)(O)[C@@H](O)C(O)=O1070.2Standard non polar33892256
(R)-2,3-Dihydroxy-isovalerateCC(C)(O)[C@@H](O)C(O)=O1122.0Semi standard non polar33892256

Derivatized

Derivative Name / StructureSMILESKovats RI ValueColumn TypeReference
(R)-2,3-Dihydroxy-isovalerate,1TMS,isomer #1CC(C)(O[Si](C)(C)C)[C@@H](O)C(=O)O1245.9Semi standard non polar33892256
(R)-2,3-Dihydroxy-isovalerate,1TMS,isomer #2CC(C)(O)[C@@H](O[Si](C)(C)C)C(=O)O1252.4Semi standard non polar33892256
(R)-2,3-Dihydroxy-isovalerate,1TMS,isomer #3CC(C)(O)[C@@H](O)C(=O)O[Si](C)(C)C1140.0Semi standard non polar33892256
(R)-2,3-Dihydroxy-isovalerate,2TMS,isomer #1CC(C)(O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)C(=O)O1328.4Semi standard non polar33892256
(R)-2,3-Dihydroxy-isovalerate,2TMS,isomer #2CC(C)(O[Si](C)(C)C)[C@@H](O)C(=O)O[Si](C)(C)C1290.0Semi standard non polar33892256
(R)-2,3-Dihydroxy-isovalerate,2TMS,isomer #3CC(C)(O)[C@@H](O[Si](C)(C)C)C(=O)O[Si](C)(C)C1250.7Semi standard non polar33892256
(R)-2,3-Dihydroxy-isovalerate,3TMS,isomer #1CC(C)(O[Si](C)(C)C)[C@@H](O[Si](C)(C)C)C(=O)O[Si](C)(C)C1372.0Semi standard non polar33892256
(R)-2,3-Dihydroxy-isovalerate,1TBDMS,isomer #1CC(C)(O[Si](C)(C)C(C)(C)C)[C@@H](O)C(=O)O1517.1Semi standard non polar33892256
(R)-2,3-Dihydroxy-isovalerate,1TBDMS,isomer #2CC(C)(O)[C@@H](O[Si](C)(C)C(C)(C)C)C(=O)O1487.9Semi standard non polar33892256
(R)-2,3-Dihydroxy-isovalerate,1TBDMS,isomer #3CC(C)(O)[C@@H](O)C(=O)O[Si](C)(C)C(C)(C)C1368.5Semi standard non polar33892256
(R)-2,3-Dihydroxy-isovalerate,2TBDMS,isomer #1CC(C)(O[Si](C)(C)C(C)(C)C)[C@@H](O[Si](C)(C)C(C)(C)C)C(=O)O1778.3Semi standard non polar33892256
(R)-2,3-Dihydroxy-isovalerate,2TBDMS,isomer #2CC(C)(O[Si](C)(C)C(C)(C)C)[C@@H](O)C(=O)O[Si](C)(C)C(C)(C)C1738.7Semi standard non polar33892256
(R)-2,3-Dihydroxy-isovalerate,2TBDMS,isomer #3CC(C)(O)[C@@H](O[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C1714.2Semi standard non polar33892256
(R)-2,3-Dihydroxy-isovalerate,3TBDMS,isomer #1CC(C)(O[Si](C)(C)C(C)(C)C)[C@@H](O[Si](C)(C)C(C)(C)C)C(=O)O[Si](C)(C)C(C)(C)C2011.9Semi standard non polar33892256
Spectra
Biological Properties
Cellular LocationsNot Available
Biospecimen Locations
  • Feces
  • Saliva
  • Urine
Tissue LocationsNot Available
Pathways
Normal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
FecesDetected but not QuantifiedNot QuantifiedAdult (>18 years old)Both
Normal		 details
FecesDetected but not QuantifiedNot QuantifiedAdult (>18 years old)Both
Normal		 details
FecesDetected but not QuantifiedNot QuantifiedAdult (>18 years old)Both
Normal		 details
SalivaDetected but not QuantifiedNot QuantifiedAdult (>18 years old)Male
Normal		 details
SalivaDetected but not QuantifiedNot QuantifiedAdult (>18 years old)Male
Normal		 details
SalivaDetected but not QuantifiedNot QuantifiedAdult (>18 years old)Male
Normal		 details
SalivaDetected but not QuantifiedNot QuantifiedAdult (>18 years old)Male
Normal		 details
SalivaDetected but not QuantifiedNot QuantifiedAdult (>18 years old)Male
Normal		 details
SalivaDetected but not QuantifiedNot QuantifiedAdult (>18 years old)Male
Normal		 details
SalivaDetected but not QuantifiedNot QuantifiedAdult (>18 years old)Male
Normal		 details
SalivaDetected but not QuantifiedNot QuantifiedAdult (>18 years old)Male
Normal		 details
SalivaDetected but not QuantifiedNot QuantifiedAdult (>18 years old)Male
Normal		 details
SalivaDetected but not QuantifiedNot QuantifiedAdult (>18 years old)Male
Normal		 details
UrineDetected and Quantified<25 umol/mmol creatinineNot SpecifiedNot SpecifiedNormal details
Abnormal Concentrations
BiospecimenStatusValueAgeSexConditionReferenceDetails
FecesDetected but not QuantifiedNot QuantifiedAdult (>18 years old)Both
Metastatic melanoma		 details
FecesDetected but not QuantifiedNot QuantifiedAdult (>18 years old)Both
Colorectal cancer		 details
SalivaDetected but not QuantifiedNot QuantifiedAdult (>18 years old)MaleAttachment loss  details
SalivaDetected but not QuantifiedNot QuantifiedAdult (>18 years old)MaleMissing teeth details
SalivaDetected but not QuantifiedNot QuantifiedAdult (>18 years old)MalePeriodontal Probing Depth details
UrineDetected and Quantified782-2500 umol/mmol creatinineInfant (0-1 year old)Both
Short-chain enoyl-CoA hydratase deficiency		 details
UrineDetected and Quantified27-406 umol/mmol creatinineNot SpecifiedNot Specified
Methylmalonyl-CoA mutase deficiency		 details
UrineDetected and Quantified82-187 umol/mmol creatinineNot SpecifiedNot Specified
Propionic acidemia		 details
UrineDetected and Quantified566-704 umol/mmol creatinineChildren (1-13 years old)Female3-Hydroxyisobutyryl-coa hydrolase deficiency details
UrineDetected and Quantified638 umol/mmol creatinineNot SpecifiedNot SpecifiedCobalamin A disease details
UrineDetected and Quantified33 umol/mmol creatinineNot SpecifiedNot SpecifiedCobalamin C disease details
UrineDetected but not QuantifiedNot QuantifiedAdult (>18 years old)BothBladder cancer details
Associated Disorders and Diseases
Disease References
Metastatic melanoma
  1. Frankel AE, Coughlin LA, Kim J, Froehlich TW, Xie Y, Frenkel EP, Koh AY: Metagenomic Shotgun Sequencing and Unbiased Metabolomic Profiling Identify Specific Human Gut Microbiota and Metabolites Associated with Immune Checkpoint Therapy Efficacy in Melanoma Patients. Neoplasia. 2017 Oct;19(10):848-855. doi: 10.1016/j.neo.2017.08.004. Epub 2017 Sep 15. [PubMed:28923537 ]
Colorectal cancer
  1. Goedert JJ, Sampson JN, Moore SC, Xiao Q, Xiong X, Hayes RB, Ahn J, Shi J, Sinha R: Fecal metabolomics: assay performance and association with colorectal cancer. Carcinogenesis. 2014 Sep;35(9):2089-96. doi: 10.1093/carcin/bgu131. Epub 2014 Jul 18. [PubMed:25037050 ]
Attachment loss
  1. Liebsch C, Pitchika V, Pink C, Samietz S, Kastenmuller G, Artati A, Suhre K, Adamski J, Nauck M, Volzke H, Friedrich N, Kocher T, Holtfreter B, Pietzner M: The Saliva Metabolome in Association to Oral Health Status. J Dent Res. 2019 Jun;98(6):642-651. doi: 10.1177/0022034519842853. Epub 2019 Apr 26. [PubMed:31026179 ]
Missing teeth
  1. Liebsch C, Pitchika V, Pink C, Samietz S, Kastenmuller G, Artati A, Suhre K, Adamski J, Nauck M, Volzke H, Friedrich N, Kocher T, Holtfreter B, Pietzner M: The Saliva Metabolome in Association to Oral Health Status. J Dent Res. 2019 Jun;98(6):642-651. doi: 10.1177/0022034519842853. Epub 2019 Apr 26. [PubMed:31026179 ]
Periodontal Probing Depth
  1. Liebsch C, Pitchika V, Pink C, Samietz S, Kastenmuller G, Artati A, Suhre K, Adamski J, Nauck M, Volzke H, Friedrich N, Kocher T, Holtfreter B, Pietzner M: The Saliva Metabolome in Association to Oral Health Status. J Dent Res. 2019 Jun;98(6):642-651. doi: 10.1177/0022034519842853. Epub 2019 Apr 26. [PubMed:31026179 ]
Methylmalonyl-CoA mutase deficiency
  1. Peters H, Ferdinandusse S, Ruiter JP, Wanders RJ, Boneh A, Pitt J: Metabolite studies in HIBCH and ECHS1 defects: Implications for screening. Mol Genet Metab. 2015 Aug;115(4):168-73. doi: 10.1016/j.ymgme.2015.06.008. Epub 2015 Jun 24. [PubMed:26163321 ]
3-Hydroxyisobutyryl-coa hydrolase deficiency
  1. Peters H, Ferdinandusse S, Ruiter JP, Wanders RJ, Boneh A, Pitt J: Metabolite studies in HIBCH and ECHS1 defects: Implications for screening. Mol Genet Metab. 2015 Aug;115(4):168-73. doi: 10.1016/j.ymgme.2015.06.008. Epub 2015 Jun 24. [PubMed:26163321 ]
Cobalamin A disease
  1. Peters H, Ferdinandusse S, Ruiter JP, Wanders RJ, Boneh A, Pitt J: Metabolite studies in HIBCH and ECHS1 defects: Implications for screening. Mol Genet Metab. 2015 Aug;115(4):168-73. doi: 10.1016/j.ymgme.2015.06.008. Epub 2015 Jun 24. [PubMed:26163321 ]
Methylmalonic aciduria and homocystinuria, cblC type
  1. Peters H, Ferdinandusse S, Ruiter JP, Wanders RJ, Boneh A, Pitt J: Metabolite studies in HIBCH and ECHS1 defects: Implications for screening. Mol Genet Metab. 2015 Aug;115(4):168-73. doi: 10.1016/j.ymgme.2015.06.008. Epub 2015 Jun 24. [PubMed:26163321 ]
Associated OMIM IDs
  • 114500 (Colorectal cancer)
  • 250620 (3-Hydroxyisobutyryl-coa hydrolase deficiency)
  • 277400 (Methylmalonic aciduria and homocystinuria, cblC type)
DrugBank IDNot Available
Phenol Explorer Compound IDNot Available
FooDB IDFDB028799
KNApSAcK IDNot Available
Chemspider ID389255
KEGG Compound IDC04272
BioCyc IDCPD-13357
BiGG IDNot Available
Wikipedia LinkNot Available
METLIN IDNot Available
PubChem Compound440279
PDB IDNot Available
ChEBI ID15684
Food Biomarker OntologyNot Available
VMH ID23DHMB
MarkerDB IDNot Available
Good Scents IDNot Available
References
Synthesis ReferenceNot Available
Material Safety Data Sheet (MSDS)Not Available
General References
  1. Simons K, Toomre D: Lipid rafts and signal transduction. Nat Rev Mol Cell Biol. 2000 Oct;1(1):31-9. [PubMed:11413487 ]
  2. Watson AD: Thematic review series: systems biology approaches to metabolic and cardiovascular disorders. Lipidomics: a global approach to lipid analysis in biological systems. J Lipid Res. 2006 Oct;47(10):2101-11. Epub 2006 Aug 10. [PubMed:16902246 ]
  3. Sethi JK, Vidal-Puig AJ: Thematic review series: adipocyte biology. Adipose tissue function and plasticity orchestrate nutritional adaptation. J Lipid Res. 2007 Jun;48(6):1253-62. Epub 2007 Mar 20. [PubMed:17374880 ]
  4. Lingwood D, Simons K: Lipid rafts as a membrane-organizing principle. Science. 2010 Jan 1;327(5961):46-50. doi: 10.1126/science.1174621. [PubMed:20044567 ]
  5. Gunstone, Frank D., John L. Harwood, and Albert J. Dijkstra (2007). The lipid handbook with CD-ROM. CRC Press.